Philomena Colucci
Incyte Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Philomena Colucci as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:02 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05949632 · A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid TumorsIncyte Corporation · terminated · Advanced Solid Tumors · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 19:02 UTC. The ranking covers the 200 most relevant of 10 PubMed records, and a shared surname and initials can bring in a namesake. All 10 on PubMed
- Enhanced brain activity associated with memory access in highly superior autobiographical memory.Proc Natl Acad Sci U S A · 201848 citationsRCR 2.1
- Pharmacokinetic equivalence of a levothyroxine sodium soft capsule manufactured using the new food and drug administration potency guidelines in healthy volunteers under fasting conditions.Ther Drug Monit · 201146 citationsRCR 1.8
- 22 citationsRCR 0.5
- Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 × 109/L): Final Analysis of an Open-Label Phase 2 Study.Clin Lymphoma Myeloma Leuk · 202216 citationsRCR 1.3
- Folate supplementation in peritoneal dialysis patients with normal erythrocyte folate: effect on plasma homocysteine.Nephron · 200113 citationsRCR 0.4
- 11 citationsRCR 2.2
- Effect of a single dose of ritonavir on the pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered in healthy volunteers.Antimicrob Agents Chemother · 20097 citationsRCR 0.2
- 6 citationsRCR 0.2
- 6 citationsRCR 3.0
- Effect of Food on the Pharmacokinetics of Single- and Multiple-Dose Hydrocodone Extended Release in Healthy Subjects.Clin Drug Investig · 20171 citationsRCR 0.1